Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 362 shares, a decline of 48.5% from the July 15th total of 703 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 2,039 shares, the short-interest ratio is currently 0.2 days.
Gyrodyne Price Performance
GYRO traded down $0.01 during midday trading on Tuesday, hitting $5.47. 5,612 shares of the company were exchanged, compared to its average volume of 1,856. The company’s 50 day simple moving average is $5.86 and its 200 day simple moving average is $7.24. Gyrodyne has a 1-year low of $5.31 and a 1-year high of $11.00.
Institutional Investors Weigh In On Gyrodyne
An institutional investor recently bought a new stake in Gyrodyne stock. Advisory Services Network LLC bought a new stake in shares of Gyrodyne , LLC (NASDAQ:GYRO – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,720 shares of the real estate investment trust’s stock, valued at approximately $77,000. Advisory Services Network LLC owned approximately 0.35% of Gyrodyne at the end of the most recent reporting period. Hedge funds and other institutional investors own 71.36% of the company’s stock.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
